A Canadian cannabis nursery has announced a partnership with a New Zealand medical cannabis company to import and distribute unique cannabis genetics from the region of Tairawhiti. The deal will also open up new markets for the New Zealand cultivar in Europe, North America, and Australasia.
Apollo Green to Offer Rua Bioscience’s Cultivar
Apollo Green, a subsidiary of Australian Biortica Agrimed, is a cannabis nursery that specializes in unique genetics and plant breeder’s rights protection. The company has signed an agreement with Rua Bioscience, a New Zealand-based medical cannabis company, to import and offer their unique cultivar to licensed cultivators worldwide.
The cultivar, which originates from the region of Tairawhiti on the east coast of New Zealand’s North Island, is said to have landrace traits that are different from the typical North American genetics. Landrace strains are cannabis varieties that have adapted to their natural environment over generations and have distinct characteristics and effects.
Apollo Green expects to carry the Rua Bioscience cultivar at a future date, once it receives the necessary approvals from Health Canada and the New Zealand Ministry of Health. The company says it is on a mission to offer curated phenotypes from reputable breeders from all over the world, and that the partnership with Rua Bioscience is one of many.
Rua Bioscience to Expand Global Presence
Rua Bioscience, formerly known as Hikurangi Cannabis, is a medical cannabis company that was founded by a group of indigenous Maori people in 2016. The company has a license to cultivate, research, and export cannabis products, and has a vision to take its unique strains to the world.
The partnership with Apollo Green and Biortica Agrimed will allow Rua Bioscience to access existing sales channels in Europe, North America, and Australasia, where there is a growing demand for medical cannabis products. The company also plans to export its genetics for cultivation at scale in high-value EU markets, such as Germany, once it receives the necessary licenses from the NZ Ministry of Health.
Rua Bioscience’s CEO Paul Naske said that the agreement is more than just a business deal, but a bridge connecting New Zealand’s exceptional cannabis genetics to the world. He added that the company is excited to join the Apollo Green and Biortica Agrimed family, and to share its cultural values and knowledge with the global cannabis community.
A Win-Win Situation for Both Parties
The strategic partnership between Apollo Green and Rua Bioscience is expected to benefit both parties, as well as the cannabis industry and consumers. By combining Apollo Green’s advanced cell-culturing technology with Rua Bioscience’s proprietary genetics, the two companies will be able to offer a superior product that is consistent, stable, and diverse.
The partnership will also help diversify and refresh the cannabis genetics market, which has become saturated with high-THC cultivars that have reduced variety and genetic variability. By introducing new and unique landrace strains from New Zealand, the two companies will be able to cater to the evolving preferences and needs of cannabis consumers, who are looking for more terpene-rich, medicinal, and exotic cultivars.
The collaboration between Apollo Green and Rua Bioscience is a promising step towards leveraging the potential of cannabis genetics to power a sustainable, clean-energy future.
